Common Contracts
4 similar Underwriting Agreement contracts by Central European Media Enterprises LTD, Horizon Health Corp /De/, Recursion Pharmaceuticals, Inc., Terns Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. 30,769,230 Shares of Class A Common Stock, $0.00001 par value Underwriting AgreementUnderwriting Agreement • June 27th, 2024 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Recursion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 30,769,230 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 4,615,384 additional shares (the “Optional Shares”) of Class A common stock, par value $0.00001 per share, of the Company. The shares of Class A common stock and Class B common stock, par value $0.00001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Stock.” The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are hereinafter collectively referred to as the “Shares.”
Terns Pharmaceuticals, Inc. 12,250,000 Shares of Common Stock, Par Value $0.0001 and Pre-Funded Warrants to Purchase 14,630,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • August 16th, 2022 • Terns Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Terns Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 12,250,000 shares of common stock, par value $0.0001 per share, of the Company (the “Shares”) and pre-funded warrants to purchase an aggregate of 14,630,000 shares of common stock of the Company, at an exercise price equal to $0.0001 per share, in the form attached hereto as Exhibit B (the “Warrants”). The Shares and Warrants are herein referred to as the “Securities.” The shares of common stock of the Company issuable upon exercise of the Warrants are herein referred to as the “Warrant Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares and the exercise of the Warrants are referred to herein as the “Stock”.
Central European Media Enterprises Ltd. 4,700,000 Shares of Class A Common Stock Underwriting AgreementUnderwriting Agreement • May 10th, 2005 • Central European Media Enterprises LTD • Television broadcasting stations • New York
HORIZON HEALTH CORPORATION 1,500,000 Shares of Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • March 11th, 2005 • Horizon Health Corp /De/ • Services-misc health & allied services, nec • New York
Horizon Health Corporation, a Delaware corporation (the “Company”), proposes to issue and sell, upon the terms and subject to the conditions set forth herein, to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 1,500,000 shares (the “Underwritten Shares”) of the Common Stock, par value $0.01 per share, of the Company (the “Common Stock”), and, at the option of the Underwriters, up to an additional 225,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase additional shares of Common Stock under certain circumstances. The Rights to be attached to the Shares are to be issued pursuan
